Public procurement of antineoplastic agents used for treating breast cancer in Brazil between 2013 and 2019.

ABSTRACT:

Background

Breast cancer is the most common cancer among women in Brazil and the country's public health care system is the main care provider. Timely treatment can increase the chance of cure, prevent metastasis and improve quality of life. Effective public procurement of antineoplastic agents can therefore improve access to drug therapy. This study investigates patterns in the procurement of selected antineoplastic agents used for treating breast cancer by public bodies and avoidable expenditure on these drugs between January 2013 and December 2019.

Methods

We selected antineoplastic agents used for adjuvant or preoperative chemotherapy listed in the 2018 Breast Cancer Diagnosis and Treatment Guidelines and included in category L of the WHO Anatomical Therapeutic Chemical

SUBMITTER: Dos Santos RLB 

PROVIDER: S-EPMC9284867 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature